Pre-Approval Access to Golimumab Subcutaneous for the Treatment of Stage 3 Type-1 Diabetes Mellitus in Children and Young Adults
Keyword(s):
2000 ◽
Vol 50
◽
pp. 209-210
Keyword(s):
2009 ◽
Vol 21
(5)
◽
pp. 425-440
◽
Keyword(s):
2003 ◽
Vol 16
(5)
◽
2011 ◽
Vol 170
(8)
◽
pp. 983-987
◽
2017 ◽
Vol 11
(6)
◽
pp. 433-435
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 56
(10)
◽
pp. 44-51
◽
Keyword(s):
Keyword(s):